| Company Name: | DataTRAK International, Incorporated | | Ticker Symbol: | DATA | | | WWW Address: | www.datatrak.net | | CEO: | Laurence P. Birch | | No. of Employees: | 47 | | Common Issue Type: | CS | | Business Description: | A technology and services company, which is focused on global eClinical solutions for the clinical trials industry.
|
| | | Industry Information: | COMPUTER SOFWARE & SERVICES - Information & Delivery Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.37 |  0.0 | 0.3 | 0.37 | 0.37 | 0.34 | 0.25 | 377 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5.1 | 13.7 | 2.23 | -1.23 | 0.00 | 0.0 | 0.0 | 0.87 - 0.01 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.26 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 3.6 | mil |
| Latest Shares Outstanding | 13.7 | mil |
| Earnings pS (EPS) | -1.23 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 187,787 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 12.0 | mil |
| Float as % of Shares Outstanding | 87.9 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 9 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 108.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 73.1 | % |
| EBITDA Margin | -35.4 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | -355.9 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 3434.5 | % |
| Current Ratio | 1.2 | |
| Leverage Ratio (Assets/Equity) | 0.0 | |
| Interest Cover | 534.1 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.04 | $ |
| Cash pS | 0.15 | $ |
| Book-Value pS | 0.00 | $ |
| Tangible Book-Value pS | -0.03 | $ |
| Cash Flow pS | -1.05 | $ |
| Free Cash Flow pS | -0.25 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.00 | |
| Price/Tangible Book Ratio | -8.67 | |
| Price/Cash Flow | -0.2 | |
| Price/Free Cash Flow | -1.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -25.7 | 72 | 206 | 1,116 |
| 4 Weeks | 0.57 | 0.23 | 0.30 | -13.3 | 83 | 339 | 6,439 |
| 13 Weeks | 0.57 | 0.09 | 0.12 | 116.7 | 173 | 266 | 16,729 |
| 26 Weeks | 0.57 | 0.09 | 0.25 | 4.0 | 101 | 325 | 40,268 |
| 52 Weeks | 0.87 | 0.01 | 0.62 | -58.1 | 64 | 316 | 79,192 |
| YTD | 0.57 | 0.09 | - | 23.8 | 122 | 307 | 31,309 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.31 | 0.33 | 0.28 | 0.22 | 0.24 | 2.23 | 2.01 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -1.26 | 0.6 | -20.32 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -35.66 | NA | -78.97 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -0.1 | -0.1 | -16.4 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.10 | 0.10 | -0.41 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 18.49 |
| Current Ratio | 1.3 |
| Quick Ratio (Acid Test) | 1.1 |
| Liquidity Ratio (Cash) | 0.90 |
| Receivables Turnover | 8.8 |
| Average Collection Period | 41 |
| Working Capital/Equity | 267.6 |
| Working Capital pS | 0.06 |
| Cash-Flow pS | -1.12 |
| Free Cash-Flow pS | -0.39 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -14.07 |
| Financial Leverage Ratio (Assets/Equity) | 14.5 |
| Debt Ratio | 93.1 |
| Total Debt/Equity (Gearing Ratio) | 0.74 |
| LT Debt/Equity | 0.13 |
| LT Debt/Capital Invested | 398.6 |
| LT Debt/Total Liabilities | 1.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 1.92 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.61 |
| Tobin's Q Ratio | 0.77 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -1.27 |
| Enterprise Value (EV)/Free Cash Flow | -1.83 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -8.67 |
| Price/Book Ratio - LTM | 0.00 |
| Price/Cash Flow Ratio | -0.2 |
| Price/Free Cash Flow Ratio - LTM | -1.0 |
| Price/Sales Ratio | 0.41 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.21 |
| Tangible Book Value pS - LTM | -0.03 |
| Book Value pS - LTM | 0.00 |
| Capital Invested pS | 0.03 |
| Cash pS - LTM | 0.15 |
| Cash Flow pS - LTM | -1.05 |
| Free Cash Flow pS - LTM | -0.25 |
| Earnings pS (EPS) | -1.23 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -60.59 |
| Free Cash Flow Margin 5YEAR AVG | -27.87 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | -44.9 |
| Equity Productivity | 27.50 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 24.31 |
| Return on Capital Invested (ROCI) | -4627.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -43.7 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | -361.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | -33.3 |
| Gross Profit Margin | 73.1 |
| Gross Profit Margin - 5YEAR AVRG. | 70.3 |
| EBITDA Margin - LTM | -35.4 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -44.7 |
| Effective Tax Rate | -2.3 |
| Effective Tax Rate - 5YEAR AVRG. | -23.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 38 |
| Revenue per Employee | 187,787 |
| Net Income per Employee | -357,383 |
| Average Collection Period | 38 |
| Receivables Turnover | 8.8 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 8.17 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 10.27 |
| Fixed Assets Turnover | 9.70 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 4.71 |
| Revenue per $ Plant | 11.23 |
| Revenue per $ Common Equity | 27.50 |
| Revenue per $ Capital Invested | 24.31 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 115.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 83.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |